Megan E. Hartranft

Evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patients

Megan E. Hartranft, Amber B. Clemmons, David L. DeRemer et al. · Journal of Oncology Pharmacy Practice · 2015 · 24 citations

Medicine, Hematology, Pharmacotherapy +17

“Triple Phase” Budesonide Capsules for the Treatment of Olmesartan-Induced Enteropathy

Megan E. Hartranft, Randolph E. Regal · Annals of Pharmacotherapy · 2014 · 18 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Flipped script for gefitinib: A reapproved tyrosine kinase inhibitor for first-line treatment of epidermal growth factor receptor mutation positive metastatic nonsmall cell lung cancer

Brian S Bogdanowicz, Matthew A Hoch, Megan E. Hartranft · Journal of Oncology Pharmacy Practice · 2016 · 14 citations

Medicine, Oncology, Pharmacology +15

A Dicarboxylic Fatty Acid Derivative of Paclitaxel for Albumin-Assisted Drug Delivery

Michael Hackett, Shyamsunder Joolakanti, Megan E. Hartranft et al. · Journal of Pharmaceutical Sciences · 2012 · 10 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +14